Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV003555956 | SCV004298136 | pathogenic | not provided | 2023-05-26 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 6954). Disruption of this splice site has been observed in individuals with deafness (PMID: 11735029, 26763877). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (no rsID available, gnomAD 0.007%). This sequence change affects a donor splice site in intron 4 of the MYO15A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in MYO15A are known to be pathogenic (PMID: 17546645). |
OMIM | RCV000007369 | SCV000027568 | pathogenic | Autosomal recessive nonsyndromic hearing loss 3 | 2001-11-01 | no assertion criteria provided | literature only |